|
1
|
Canonica GW, Senna G, Mitchell PD, O'Byrne
PM, Passalacqua G and Varricchi G: Therapeutic interventions in
severe asthma. World Allergy Organ J. 9:402016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung LP, Baltic S, Ferreira M, Temple S,
Waterer G and Thompson PJ: Beta2 adrenergic receptor (ADRβ2)
haplotype pair (2/4) is associated with severe asthma. PLoS One.
9:e936952014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grieger JA, Wood LG and Clifton VL:
Improving asthma during pregnancy with dietary antioxidants: The
current evidence. Nutrients. 5:3212–3234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jung JW, Choi JC, Shin JW, Kim JY, Park IW
and Choi BW: Clinical characteristics according to sensitized
allergens in adult korean patients with bronchial asthma. Allergy
Asthma Immunol Res. 2:102–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akpinarli A, Tuncer A, Saraçlar Y, Sekerel
BE and Kalayci O: Effect of formoterol on clinical parameters and
lung functions in patients with bronchial asthma: A randomised
controlled trial. Arch Dis Child. 81:45–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scott M, Raza A, Karmaus W, Mitchell F,
Grundy J, Kurukulaaratchy RJ, Arshad SH and Roberts G: Influence of
atopy and asthma on exhaled nitric oxide in an unselected birth
cohort study. Thorax. 65:258–262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scaparrotta A, Di Pillo S, Attanasi M,
Rapino D, Cingolani A, Consilvio NP, Verini M and Chiarelli F:
Montelukast versus inhaled corticosteroids in the management of
pediatric mild persistent asthma. Multidiscip Respir Med. 7:132012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jindal A, Suriyan S, Sagadevan S,
Narasimhan M, Shanmuganathan A, Vallabhaneni V and Rajalingam R:
Comparison of oral montelukast and intranasal fluticasone in
patients with asthma and allergic rhinitis. J Clin Diagn Res.
10:OC06–OC10. 2016.PubMed/NCBI
|
|
9
|
Ciebiada MG, Barylski M and Ciebiada M:
Wheal and flare reactions in skin prick tests of patients treated
with montelukast alone or in combination with antihistamines.
Inflamm Res. 63:191–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bao W, Liu P, Qiu Z, Yu L, Hang J, Gao X
and Zhou X: Efficacy of add-on montelukast in nonasthmatic
eosinophilic bronchitis: The additive effect on airway
inflammation, cough and life quality. Chin Med J (Engl). 128:39–45.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee J-H, Yu H-H, Wang L-C, Yang Y-H, Lin
Y-T and Chiang B-L: The levels of CD4+CD25+
regulatory T cells in paediatric patients with allergic rhinitis
and bronchial asthma. Clin Exp Immunol. 148:53–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watanabe T, Fajt ML, Trudeau JB, Voraphani
N, Hu H, Zhou X, Holguin F and Wenzel SE: Brain-derived
neurotrophic factor expression in asthma. Association with severity
and type 2 inflammatory processes. Am J Respir Cell Mol Biol.
53:844–852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
FitzGerald JM, Foucart S, Coyle S,
Sampalis J, Haine D, Psaradellis E and McIvor RA: Montelukast as
add-on therapy to inhaled corticosteroids in the management of
asthma (the SAS trial). Can Respir J. 16 Suppl A:5A–14A. 2009.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reiss TF, Hill JB, Harman E, Zhang J,
Tanaka WK, Bronsky E, Guerreiro D and Hendeles L: Increased urinary
excretion of LTE4 after exercise and attenuation of
exercise-induced bronchospasm by montelukast, a cysteinyl
leukotriene receptor antagonist. Thorax. 52:1030–1035. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Keith PK, Koch C, Djandji M, Bouchard J,
Psaradellis E, Sampalis JS, Schellenberg RR and McIvor RA:
Montelukast as add-on therapy with inhaled corticosteroids or
inhaled corticosteroids and long-acting beta-2-agonists in the
management of patients diagnosed with asthma and concurrent
allergic rhinitis (the RADAR trial). Can Respir J. 16 Suppl
A:17A–31A. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernstein JM, Lehman H, Lis M, Sands A,
Wilding GE, Shultz L, Bankert R and Bobek L: Humanized mouse model
used to monitor MUC gene expression in nasal polyps and to
preclinically evaluate the efficacy of montelukast in reducing
mucus production. Ann Otol Rhinol Laryngol. 121:307–316. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han J, Jia Y, Takeda K, Shiraishi Y,
Okamoto M, Dakhama A and Gelfand EW: Montelukast during primary
infection prevents airway hyperresponsiveness and inflammation
after reinfection with respiratory syncytial virus. Am J Respir
Crit Care Med. 182:455–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kianmehr M, Haghmorad D, Nosratabadi R,
Rezaei A, Alavinezhad A and Boskabady MH: The effect of Zataria
multiflora on Th1/Th2 and Th17/T regulatory in a mouse model of
allergic asthma. Front Pharmacol. 8:4582017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rolfes MC, Juhn YJ, Wi C-I and Sheen YH:
Asthma and the risk of rheumatoid arthritis: An insight into the
heterogeneity and phenotypes of asthma. Tuberc Respir Dis (Seoul).
80:113–135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui A-H, Zhao J, Liu S-X and Hao Y-S:
Associations of IL-4, IL-6, and IL-12 levels in peripheral blood
with lung function, cellular immune function, and quality of life
in children with moderate-to-severe asthma. Medicine (Baltimore).
96:e62652017. View Article : Google Scholar : PubMed/NCBI
|
